Swaziland

Exploring the Potential of Participatory Theatre to Reduce Stigma and Promote Health Equity for Lesbian, Gay, Bisexual, and Transgender (LGBT) People in Swaziland and Lesotho

Stigma and discrimination affecting lesbian, gay, bisexual, and transgender (LGBT) people compromise health and human rights and exacerbate the HIV epidemic. Scant research has explored effective LGBT stigma reduction strategies in low- and middle-income countries. We developed and pilot-tested a participatory theatre intervention (PTI) to reduce LGBT stigma in Swaziland and Lesotho, countries with the world's highest HIV prevalence. We collected preliminary data from in-depth interviews with LGBT people in Lesotho and Swaziland to enhance understanding of LGBT stigma.

Include in home page features rotation
Off

Study finds HIV care, diagnosis barriers for men fueling epidemic among young women

Young women who have sexual relationships with older men often are dealing with inequitable power dynamics, little capacity to negotiate safe sex or to refuse sex, and—therefore —a greater risk of acquiring HIV. In sub-Saharan Africa, adolescent girls and young women are disproportionately affected by HIV, which has led to a heightened emphasis on understanding the characteristics of their male sexual partners. It also points attention to the fact that men are less often reached with HIV testing, care, and continued treatment—the 90-90-90 HIV care cascade.

Author
Zahra Reynolds, MEASURE Evaluation
Source
Science Speaks

Consultancy: Eswatini National Essential Medicines and Standard Treatment Guidelines Review

Closing date
Currently, there is a Standard Treatment Guideline and Essential Medicines List (STG/EML) available for use by health workers at public health care settings in Eswatini; which was published in 2012. Considering the numerous changes in policies, guidelines, and new scientific evidence that informs clinical practice, there is a compelling need to revise and update this guideline so that it remains relevant to the users. It’s widely believed that the current STG has not been used extensively due to a number of factors. TSP/SC-PASS has obtained approval from the Principal Secretary, MOH, Eswatini to support the review, update of the treatment guideline and hereby wishes to engage the services of competent consultant(s) to undertake some aspects of this project as specified below.

Management Information Systems (MIS) Technical Advisor

Closing date

Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are implementing the Supply Chain and Pharmaceutical Assistance for Sustainable Systems (SC-PASS) Project in eSwatini. SC-PASS seeks to improve the delivery and consistent use of HIV, TB and other reproductive health commodities and essential pharmaceutical services to achieve desired HIV, TB and SRH health outcomes. 

Retention of children under 18 months testing HIV positive in care in Swaziland: a retrospective study

Author
Sikhondze N, Mahomed OH

 

INTRODUCTION:
Significant progress has been made with respect to the initiation of children on antiretroviral therapy (ART) in Southern Africa, including Swaziland, however, retention of these children in care poses a major challenge. The aim of the study was to assess retention to care in children testing HIV positive taking into account the number of return child welfare care (CWC) visits the child made.

Include in home page features rotation
Off

The economies of scale of test and treat: A longitudinal costing study in Eswatini

Is the resource available on the Internet?
Yes
Author
Shaukat Khan, Cebele Wong, Pascal Geldsetzer, Gerda Asmus, Thomas How, Charlotte Lejeune, Velephi Okello, Till Bärnighausen

Swaziland has one of the highest adult HIV prevalence rates worldwide, 27%; with approximately 200,000 people 15 years and older living with HIV. Swaziland and many other countries in sub-Saharan Africa have adopted universal test-and-treat (UTT) policies. As the number of people needing and receiving ART in Swaziland is rapidly increasing, it is critical to understand the cost of UTT scale-up and its implications for the health system.

Include in home page features rotation
Off

Scaling Up Voluntary Medical Male Circumcision for Human Immunodeficiency Virus Prevention for Adolescents and Young Adult Men: A Modeling Analysis of Implementation and Impact in Selected Countries

Is the resource available on the Internet?
Yes
Author
Emmanuel Njeuhmeli, Marjorie Opuni, Melissa Schnure, Michel Tchuenche, Peter Stegman, Elizabeth Gold, Valerian Kiggundu, Nida Parks, Kim Seifert Ahanda, Maria Carrasco, Katharine Kripke

Background

The new World Health Organization and Joint United Nations Programme on HIV/AIDS strategic framework for voluntary medical male circumcision (VMMC) aims to increase VMMC coverage among males aged 10–29 years in priority settings to 90% by 2021. We use mathematical modeling to assess the likelihood that selected countries will achieve this objective, given their historical VMMC progress and current implementation options.

Methods

Include in home page features rotation
Off

Pharmaceutical Senior Technical Advisor (Baylor College of Medicine Children's Foundation Swaziland)

Closing date

Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are partners in continuing the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program in Swaziland. The new project, Swaziland Supply Chain and Pharmaceutical Assistance for Sustainable Systems (SC+PASS) seeks to improve the delivery and consistent use of HIV, TB and other reproductive health commodities and essential pharmaceutical services to achieve desired HIV, TB and SRH health outcomes.

Technical Advisor- Rationale Medicines Use (Baylor College of Medicine Children's Foundation Swaziland)

Closing date

Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are partners in continuing the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program in Swaziland. The new project, Swaziland Supply Chain and Pharmaceutical Assistance for Sustainable Systems (SC+PASS) seeks to improve the delivery and consistent use of HIV, TB and other reproductive health commodities and essential pharmaceutical services to achieve desired HIV, TB and SRH health outcomes.

Subscribe to Swaziland